-
National Institutes of Health makes a strategic plan for a biodefence research facility to accomplish short and long term goals against bioterrorism. (BU Medical Campus)
-
Boston University Medical Center was awarded a grant from the National Institute of Allergy and Infectious Disease to build one of two National Biocontainment Laboratories (BU medical campus)
-
Two researchers studying tularemia fall ill after being infected and another in September as well. By the end of October 2004 the study on tularemia was stopped. (Boston Globe)
-
The consteuction on the lab was completed in the Fall of 2008 and cost a total of $128 million. (BU Medical Campus)
The lab is located at 620 Albany St. in Boston’s South End. Located near a food bank, prison, good will store and public housing. -
The National Emerging Infectious Diseases Laboratories (NEIDL) is part of a national network of secure facilities studying infectious diseases that are or have the potential to become major public health concerns.
-
- To perform cutting-edge research on emerging infectious diseases and to develop diagnostic tests, treatments, and vaccines to promote the public’s health through combating infectious diseases.
- To provide training in these areas of research and to support a national response in the event of a biodefense emergency.
- To establish a research facility with the highest attention to community and laboratory safety and security.
-
During a National Institutes of Health Blue Ribbon Panel there was a debate over the safety of Boston University’s Biosafety Level-4 laboratory. (Daily Press)
-
Boston Mayor Thomas M. Menino led a tour of (NEIDL). The tour was designed to highlight both the safety features and the prospective economic impact of the facility, which the city estimates at $98 million per year. (BU Medical Campus)
